Laparoscopy  ||| S:0 E:12 ||| JJ
staging  ||| S:12 E:20 ||| NN
of  ||| S:20 E:23 ||| IN
early  ||| S:23 E:29 ||| JJ
ovarian  ||| S:29 E:37 ||| JJ
cancer ||| S:37 E:43 ||| NN
:  ||| S:43 E:45 ||| :
our  ||| S:45 E:49 ||| PRP$
experience  ||| S:49 E:60 ||| NN
and  ||| S:60 E:64 ||| CC
review  ||| S:64 E:71 ||| NN
of  ||| S:71 E:74 ||| IN
the  ||| S:74 E:78 ||| DT
literature  ||| S:78 E:89 ||| NN
We  ||| S:89 E:92 ||| PRP
report  ||| S:92 E:99 ||| VB
our  ||| S:99 E:103 ||| PRP$
experience  ||| S:103 E:114 ||| NN
with  ||| S:114 E:119 ||| IN
laparoscopic  ||| S:119 E:132 ||| JJ
staging  ||| S:132 E:140 ||| NN
of  ||| S:140 E:143 ||| IN
apparent  ||| S:143 E:152 ||| JJ
early  ||| S:152 E:158 ||| JJ
ovarian  ||| S:158 E:166 ||| JJ
cancer ||| S:166 E:172 ||| NN
,  ||| S:172 E:174 ||| ,
and  ||| S:174 E:178 ||| CC
we  ||| S:178 E:181 ||| PRP
critically  ||| S:181 E:192 ||| RB
review  ||| S:192 E:199 ||| VB
the  ||| S:199 E:203 ||| DT
current  ||| S:203 E:211 ||| JJ
literature  ||| S:211 E:222 ||| NN
on  ||| S:222 E:225 ||| IN
this  ||| S:225 E:230 ||| DT
issue ||| S:230 E:235 ||| NN
.  ||| S:235 E:237 ||| .
Potential  ||| S:237 E:247 ||| JJ
limits  ||| S:247 E:254 ||| NNS
of  ||| S:254 E:257 ||| IN
laparoscopic  ||| S:257 E:270 ||| JJ
technique  ||| S:270 E:280 ||| NN
and  ||| S:280 E:284 ||| CC
theoretical  ||| S:284 E:296 ||| JJ
concerns  ||| S:296 E:305 ||| NNS
of  ||| S:305 E:308 ||| IN
using  ||| S:308 E:314 ||| VBG
pneumoperitoneum-based  ||| S:314 E:337 ||| JJ
surgery  ||| S:337 E:345 ||| NN
in  ||| S:345 E:348 ||| IN
this  ||| S:348 E:353 ||| DT
setting  ||| S:353 E:361 ||| NN
are  ||| S:361 E:365 ||| VBP
addressed ||| S:365 E:374 ||| VBN
.  ||| S:374 E:376 ||| .
Surgical ||| S:376 E:384 ||| NNP
,  ||| S:384 E:386 ||| ,
pathological ||| S:386 E:398 ||| NN
,  ||| S:398 E:400 ||| ,
and  ||| S:400 E:404 ||| CC
oncological  ||| S:404 E:416 ||| JJ
outcome  ||| S:416 E:424 ||| NN
data  ||| S:424 E:429 ||| NNS
of  ||| S:429 E:432 ||| IN
consecutive  ||| S:432 E:444 ||| JJ
patients  ||| S:444 E:453 ||| NNS
undergoing  ||| S:453 E:464 ||| VBG
comprehensive  ||| S:464 E:478 ||| JJ
laparoscopic  ||| S:478 E:491 ||| JJ
staging  ||| S:491 E:499 ||| NN
for  ||| S:499 E:503 ||| IN
presumed  ||| S:503 E:512 ||| JJ
early  ||| S:512 E:518 ||| JJ
ovarian  ||| S:518 E:526 ||| JJ
cancer  ||| S:526 E:533 ||| NN
at  ||| S:533 E:536 ||| IN
our  ||| S:536 E:540 ||| PRP$
institution  ||| S:540 E:552 ||| NN
were  ||| S:552 E:557 ||| VBD
prospectively  ||| S:557 E:571 ||| RB
collected ||| S:571 E:580 ||| VBN
.  ||| S:580 E:582 ||| .
The  ||| S:582 E:586 ||| DT
median  ||| S:586 E:593 ||| JJ
operative  ||| S:593 E:603 ||| JJ
time  ||| S:603 E:608 ||| NN
was  ||| S:608 E:612 ||| VBD
348  ||| S:612 E:616 ||| CD
minutes  ||| S:616 E:624 ||| NNS
( ||| S:624 E:625 ||| -LRB-
range ||| S:625 E:630 ||| NN
,  ||| S:630 E:632 ||| ,
255-450  ||| S:632 E:640 ||| CD
minutes ||| S:640 E:647 ||| NNS
) ||| S:647 E:648 ||| -RRB-
.  ||| S:648 E:650 ||| .
The  ||| S:650 E:654 ||| DT
median  ||| S:654 E:661 ||| JJ
estimated  ||| S:661 E:671 ||| JJ
blood  ||| S:671 E:677 ||| NN
loss  ||| S:677 E:682 ||| NN
was  ||| S:682 E:686 ||| VBD
250  ||| S:686 E:690 ||| CD
mL  ||| S:690 E:693 ||| NNS
( ||| S:693 E:694 ||| -LRB-
range ||| S:694 E:699 ||| NN
,  ||| S:699 E:701 ||| ,
50-3000  ||| S:701 E:709 ||| NNP
mL ||| S:709 E:711 ||| NNP
) ||| S:711 E:712 ||| -RRB-
.  ||| S:712 E:714 ||| .
The  ||| S:714 E:718 ||| DT
mean  ||| S:718 E:723 ||| JJ
number  ||| S:723 E:730 ||| NN
of  ||| S:730 E:733 ||| IN
pelvic  ||| S:733 E:740 ||| JJ
and  ||| S:740 E:744 ||| CC
paraaortic  ||| S:744 E:755 ||| JJ
lymph  ||| S:755 E:761 ||| JJ
nodes  ||| S:761 E:767 ||| JJ
harvested  ||| S:767 E:777 ||| NN
was  ||| S:777 E:781 ||| VBD
24.5  ||| S:781 E:786 ||| CD
( ||| S:786 E:787 ||| -LRB-
SD ||| S:787 E:789 ||| NNP
,  ||| S:789 E:791 ||| ,
6.3 ||| S:791 E:794 ||| CD
)  ||| S:794 E:796 ||| -RRB-
and  ||| S:796 E:800 ||| CC
9.8  ||| S:800 E:804 ||| CD
( ||| S:804 E:805 ||| -LRB-
SD ||| S:805 E:807 ||| NNP
,  ||| S:807 E:809 ||| ,
7.1 ||| S:809 E:812 ||| CD
) ||| S:812 E:813 ||| -RRB-
,  ||| S:813 E:815 ||| ,
respectively ||| S:815 E:827 ||| RB
.  ||| S:827 E:829 ||| .
The  ||| S:829 E:833 ||| DT
disease  ||| S:833 E:841 ||| NN
was  ||| S:841 E:845 ||| VBD
upstaged  ||| S:845 E:854 ||| VBN
in  ||| S:854 E:857 ||| IN
6  ||| S:857 E:859 ||| CD
women  ||| S:859 E:865 ||| NNS
( ||| S:865 E:866 ||| -LRB-
23.1 ||| S:866 E:870 ||| CD
% ||| S:870 E:871 ||| NN
) ||| S:871 E:872 ||| -RRB-
.  ||| S:872 E:874 ||| .
No  ||| S:874 E:877 ||| DT
conversion  ||| S:877 E:888 ||| NN
to  ||| S:888 E:891 ||| TO
laparotomy  ||| S:891 E:902 ||| VB
and  ||| S:902 E:906 ||| CC
no  ||| S:906 E:909 ||| DT
intraoperative  ||| S:909 E:924 ||| JJ
complication  ||| S:924 E:937 ||| NN
occurred ||| S:937 E:945 ||| VBD
.  ||| S:945 E:947 ||| .
One  ||| S:947 E:951 ||| CD
patient  ||| S:951 E:959 ||| NN
had  ||| S:959 E:963 ||| VBD
a  ||| S:963 E:965 ||| DT
retroperitoneal  ||| S:965 E:981 ||| JJ
hematoma  ||| S:981 E:990 ||| NNS
recognized  ||| S:990 E:1001 ||| VBN
in  ||| S:1001 E:1004 ||| IN
the  ||| S:1004 E:1008 ||| DT
postoperative  ||| S:1008 E:1022 ||| JJ
period ||| S:1022 E:1028 ||| NN
,  ||| S:1028 E:1030 ||| ,
and  ||| S:1030 E:1034 ||| CC
this  ||| S:1034 E:1039 ||| DT
required  ||| S:1039 E:1048 ||| JJ
laparotomy  ||| S:1048 E:1059 ||| NN
and  ||| S:1059 E:1063 ||| CC
ligature  ||| S:1063 E:1072 ||| NN
of  ||| S:1072 E:1075 ||| IN
the  ||| S:1075 E:1079 ||| DT
hypogastric  ||| S:1079 E:1091 ||| JJ
arteries  ||| S:1091 E:1100 ||| NNS
to  ||| S:1100 E:1103 ||| TO
achieve  ||| S:1103 E:1111 ||| VB
hemostasis ||| S:1111 E:1121 ||| NNS
.  ||| S:1121 E:1123 ||| .
The  ||| S:1123 E:1127 ||| DT
median  ||| S:1127 E:1134 ||| JJ
follow-up  ||| S:1134 E:1144 ||| JJ
period  ||| S:1144 E:1151 ||| NN
was  ||| S:1151 E:1155 ||| VBD
26.7  ||| S:1155 E:1160 ||| CD
months  ||| S:1160 E:1167 ||| NNS
( ||| S:1167 E:1168 ||| -LRB-
range ||| S:1168 E:1173 ||| NN
,  ||| S:1173 E:1175 ||| ,
2-83  ||| S:1175 E:1180 ||| CD
months ||| S:1180 E:1186 ||| NNS
) ||| S:1186 E:1187 ||| -RRB-
.  ||| S:1187 E:1189 ||| .
Recurrence-free  ||| S:1189 E:1205 ||| JJ
survival  ||| S:1205 E:1214 ||| NN
was  ||| S:1214 E:1218 ||| VBD
96.1 ||| S:1218 E:1222 ||| CD
% ||| S:1222 E:1223 ||| NN
.  ||| S:1223 E:1225 ||| .
Our  ||| S:1225 E:1229 ||| PRP$
results  ||| S:1229 E:1237 ||| NNS
suggest  ||| S:1237 E:1245 ||| VBP
that  ||| S:1245 E:1250 ||| IN
laparoscopic  ||| S:1250 E:1263 ||| JJ
comprehensive  ||| S:1263 E:1277 ||| JJ
surgical  ||| S:1277 E:1286 ||| JJ
staging  ||| S:1286 E:1294 ||| NN
is  ||| S:1294 E:1297 ||| VBZ
a  ||| S:1297 E:1299 ||| DT
valuable  ||| S:1299 E:1308 ||| JJ
treatment  ||| S:1308 E:1318 ||| NN
option  ||| S:1318 E:1325 ||| NN
for  ||| S:1325 E:1329 ||| IN
ovarian  ||| S:1329 E:1337 ||| JJ
cancer  ||| S:1337 E:1344 ||| NN
patients  ||| S:1344 E:1353 ||| NNS
with  ||| S:1353 E:1358 ||| IN
apparent  ||| S:1358 E:1367 ||| JJ
early  ||| S:1367 E:1373 ||| JJ
disease ||| S:1373 E:1380 ||| NN
.  ||| S:1380 E:1382 ||| .
Evidence  ||| S:1382 E:1391 ||| NN
is  ||| S:1391 E:1394 ||| VBZ
beginning  ||| S:1394 E:1404 ||| VBG
to  ||| S:1404 E:1407 ||| TO
accumulate  ||| S:1407 E:1418 ||| VB
suggesting  ||| S:1418 E:1429 ||| VBG
that  ||| S:1429 E:1434 ||| IN
minimally  ||| S:1434 E:1444 ||| JJ
invasive  ||| S:1444 E:1453 ||| JJ
surgery  ||| S:1453 E:1461 ||| NN
is  ||| S:1461 E:1464 ||| VBZ
at  ||| S:1464 E:1467 ||| IN
least  ||| S:1467 E:1473 ||| JJS
equivalent  ||| S:1473 E:1484 ||| NN
in  ||| S:1484 E:1487 ||| IN
surgicopathological  ||| S:1487 E:1507 ||| JJ
outcomes  ||| S:1507 E:1516 ||| NNS
and  ||| S:1516 E:1520 ||| CC
middle-range  ||| S:1520 E:1533 ||| JJ
oncological  ||| S:1533 E:1545 ||| JJ
results  ||| S:1545 E:1553 ||| NNS
to  ||| S:1553 E:1556 ||| TO
the  ||| S:1556 E:1560 ||| DT
conventional  ||| S:1560 E:1573 ||| JJ
treatment  ||| S:1573 E:1583 ||| NN
approach ||| S:1583 E:1591 ||| NN
,  ||| S:1591 E:1593 ||| ,
and  ||| S:1593 E:1597 ||| CC
early  ||| S:1597 E:1603 ||| JJ
concerns  ||| S:1603 E:1612 ||| NNS
are  ||| S:1612 E:1616 ||| VBP
proving  ||| S:1616 E:1624 ||| VBG
largely  ||| S:1624 E:1632 ||| RB
unfounded ||| S:1632 E:1641 ||| JJ
.  ||| S:1641 E:1643 ||| .
